Home/Pipeline/Betmiga (mirabegron)

Betmiga (mirabegron)

Overactive Bladder

ApprovedCommercial

Key Facts

Indication
Overactive Bladder
Phase
Approved
Status
Commercial
Company

About Astellas Pharma

Astellas Pharma Inc. is one of Japan's leading pharmaceutical companies with a global presence, dedicated to turning innovative science into value for patients. The company has built a strong portfolio of prescription medicines and is advancing multiple programs through clinical development, with particular expertise in urology, oncology, immunology, and neuroscience. Astellas is committed to becoming a global biopharmaceutical company by leveraging external innovation and strategic partnerships.

View full company profile

Other Overactive Bladder Drugs

DrugCompanyPhase
Vesicare (solifenacin)Astellas PharmaApproved
VibegronSumitomo PharmaApproved/Commercial